MIR6778
gene geneOn this page
Also known as hsa-mir-6778
Summary
MIR6778 (microRNA 6778, HGNC:50183) is a microRNA gene on chromosome 17p11.2.
microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop.
Source: NCBI Gene 102466733 — RefSeq curated summary.
At a glance
- Gene type: non-coding (miRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:50183 |
| Approved symbol | MIR6778 |
| Name | microRNA 6778 |
| Location | 17p11.2 |
| Locus type | RNA, micro |
| Status | Approved |
| Aliases | hsa-mir-6778 |
| Ensembl gene | ENSG00000283772 |
| Ensembl biotype | miRNA |
| Entrez | 102466733 |
| RNAcentral | URS000075E4AA — ncRNA, 73 nt, 3 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 miRNA
ENST00000617912
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000617912 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003719020 | 18340814 | 18340886 |
Expression profiles
Bgee: expression breadth broad, 15 present calls, max score 71.53.
Top tissues by expression
15 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| body of stomach | UBERON:0001161 | 71.53 | gold quality |
| colon | UBERON:0001155 | 64.20 | gold quality |
| left adrenal gland | UBERON:0001234 | 62.24 | gold quality |
| putamen | UBERON:0001874 | 61.91 | gold quality |
| hypothalamus | UBERON:0001898 | 61.83 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 61.70 | gold quality |
| right frontal lobe | UBERON:0002810 | 60.76 | gold quality |
| nucleus accumbens | UBERON:0001882 | 56.33 | gold quality |
| left ovary | UBERON:0002119 | 55.30 | gold quality |
| body of pancreas | UBERON:0001150 | 54.10 | gold quality |
| omental fat pad | UBERON:0010414 | 53.04 | gold quality |
| transverse colon | UBERON:0001157 | 49.96 | gold quality |
| skin of leg | UBERON:0001511 | 46.45 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 44.08 | gold quality |
| prostate gland | UBERON:0002367 | 43.27 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 3)
- the present study revealed that circRNA CBL.11expression is significantly increased in CRC cells after carbon ion irradiation. Functionally and mechanistically, circRNA CBL.11 regulates YWHAE expression by sponging miR-6778-5p directly to suppress cell proliferation in colorectal cancer. (PMID:31438886)
- Drosha-independent miR-6778-5p strengthens gastric cancer stem cell stemness via regulation of cytosolic one-carbon folate metabolism. (PMID:32142918)
- The Drosha-Independent MicroRNA6778-5p/GSK3beta Axis Mediates the Proliferation of Gastric Cancer Cells. (PMID:36210981)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.